Delivery Order 75N92018D00005-75N92018F00001
- Not listed
- This federal contract award to the University of Alabama at Birmingham (UAB) is for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The National Heart, Lung, and Blood Institute awarded this $10,195,967.56 definitive, cost-no-fee contract to UAB, with a period of performance through June 30, 2018. The CARDIA study is a long-running longitudinal research effort focused on investigating cardiovascular disease development and risk factors in early adulthood....
- This is a federal contract award from the National Heart, Lung and Blood Institute (NHLBI) to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The $21,508,390.00 contract has an ultimate completion date of June 30, 2033 and is not set aside. The CARDIA study aims to assess the evolution of coronary artery disease risk factors in healthy young adults. UAB is the prime contractor, and key subcontractors...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $72.0 million cost-no-fee definitive contract to the University of Alabama at Birmingham (UAB) on May 21, 2004, for operation of a field center supporting the Coronary Artery Risk Development in Young Adults (CARDIA) Study. This longitudinal epidemiological research initiative tracks cardiovascular risk factors and disease development in a cohort of young adults, with the Birmingham field center responsible for participant...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study - Birmingham Field Center. The $7,699,918.00 cost-no-fee contract has a period of performance through June 30, 2034 and does not have a set-aside designation. UAB is a prominent public research university with extensive capabilities in biomedical research, clinical...
- This is a $1,050,298.53 federal contract award to the University of Alabama at Birmingham (UAB) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for Task Area B under the Coronary Artery Risk Development in Young Adults (CARDIA) program, with a period of performance from November 14, 2019, to October 31, 2021, and an ultimate completion date of January 31, 2023. UAB is the prime contractor for this cost-no-fee...
- This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to the University of Alabama at Birmingham (UAB) on July 1, 2013. The contract, valued at $3,779,804.17, is for the CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) FIELD CENTER program. The contract has an ultimate completion date of June 30, 2018 and is a Definitive Contract with a Cost No Fee pricing type. The contract does not have a set-aside designation. UAB, a public research...
- This federal contract award with ID 75N92018D00007|75N92018F00001 was issued by the National Heart Lung and Blood Institute, a civilian agency, to the University of Alabama at Birmingham (UAB) as the prime contractor. The award is for the "CARDIA BIRMINGHAM FC - TASK AREA A" project with a period of performance from July 1, 2018 to June 30, 2019, and a ceiling value of $2,288,842.69. The contract is a delivery order with a cost no fee pricing type and is not set-aside. The CARDIA...
- This is a delivery order issued under the Coronary Artery Risk Development in Young Adults (CARDIA) study contract, which is administered by the National Heart, Lung, and Blood Institute (NHLBI). The University of Alabama at Birmingham (UAB) is the prime contractor, with several subcontractors including the University of Massachusetts Medical School, Solomon Park Research Laboratories, the Medical University of South Carolina, and the University of Minnesota. The total ceiling value of this...
- The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $2,223,719.52 cost-no-fee delivery order contract to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, for the Coronary Artery Risk Development in Young Adults (CARDIA) study. This award is under a larger indefinite delivery contract with a $11 million ceiling that runs through 2034, enabling the long-running CARDIA study to continue. The University of Minnesota, a...
- The U.S. National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,639,168.37 definitive cost-reimbursement contract to The Johns Hopkins University for the Coronary Artery Risk Development in Young Adults (CARDIA) Echocardiography Reading Center. The contract, which runs through June 30, 2018, supports the CARDIA study, a long-term research initiative focused on understanding the development of cardiovascular disease. Under the contract, The Johns Hopkins University, acting as the prime...
- 75N92018D00005Indefinite Delivery Contract
- 75N92018D00005-75N92018F00001Delivery Order
The University of Alabama at Birmingham (UAB) was awarded a federal contract by the National Heart, Lung, and Blood Institute (NHLBI) for $7,967,653.41 to support the Coronary Artery Risk Development in Young Adults (CARDIA) study. The contract, which runs from July 2018 to June 2023, does not have a set-aside designation. As the prime contractor, UAB is responsible for various tasks including blood sample tracking and inventory, DNA extraction and distribution, data security, and freezer maintenance. UAB has subcontracted portions of the work to the University of Texas Health Science Center at Houston, Solomon Park Research Laboratories, and the University of Massachusetts Medical School. The overall CARDIA study aims to investigate the development and progression of cardiovascular disease in young adults, and UAB's expertise in areas such as cancer research, infectious diseases, and cardiovascular medicine positions it well to support this important long-term study.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Coronary Artery Risk Development in Young Adults ( | HHSN26818HV00015R | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 6/27/18, 10:32 AM | |
Coronary Artery Risk Development in Young Adults | HHSN26818HV00015R | Department of Health and Human Services National Institutes of Health | Award Notice 1/2 | 8/9/17, 2:18 PM |
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
000518568T001002S | University Of Texas Health Science Center At Houston | Delivery Order 75N92018D00005-75N92018F00001 | $577.0k | 10/11/21 | |
000518568T001004S | Solomon Park Research Laboratories, Inc. | Delivery Order 75N92018D00005-75N92018F00001 | $563.5k | 8/20/20 | |
000518568T001001S | Mayo Clinic | Delivery Order 75N92018D00005-75N92018F00001 | $170.6k | 6/18/20 | |
000518568T001003S | University Of Massachusetts Medical School | Delivery Order 75N92018D00005-75N92018F00001 | $144.0k | 6/16/20 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Funding Only Action | ($258k) | 11/18/24 | |
| P00008 | Other Administrative Action | ($4k) | 1/10/23 | |
| P00007 | Exercise an Option | $1.7m | 6/24/22 | |
| P00006 | Funding Only Action | ($219k) | 4/28/22 | |
| P00005 | Funding Only Action | $296.5k | 12/22/21 |